Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survival

Immune checkpoint inhibitors (ICIs) have improved the survival of patients with non-small cell lung cancer (NSCLC) by reinvigorating tumor-specific T cell responses. However, the specificity of such T cells and the human leukocyte antigen (HLA)-associated epitopes recognized, remain elusive. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Berner, Fiamma, Niederer, Rebekka, Luimstra, Jolien J., Pop, Oltin Tiberiu, Jochum, Ann-Kristin, Purde, Mette-Triin, Hasan Ali, Omar, Bomze, David, Bauer, Jens, Freudenmann, Lena Katharina, Marcu, Ana, Wolfschmitt, Eva-Maria, Haen, Sebastian, Gross, Thorben, Dubbelaar, Marissa Lisa, Abdou, Marie-Therese, Baumgaertner, Petra, Appenzeller, Christina, Cicin-Sain, Caroline, Lenz, Tobias, Speiser, Daniel E., Ludewig, Burkhard, Driessen, Christoph, Jörger, Markus, Früh, Martin, Jochum, Wolfram, Cozzio, Antonio, Rammensee, Hans-Georg, Walz, Juliane, Neefjes, Jacques, Flatz, Lukas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632109/
https://www.ncbi.nlm.nih.gov/pubmed/34858733
http://dx.doi.org/10.1080/2162402X.2021.2006893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632109/
https://www.ncbi.nlm.nih.gov/pubmed/34858733
http://dx.doi.org/10.1080/2162402X.2021.2006893

Ejemplares similares